Shares of Novavax, Inc. (NASDAQ:NVAX – Get Rating) have received a consensus rating of “Buy” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target […]
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial novavax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novavax.com Daily Mail and Mail on Sunday newspapers.
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.